Stem cell and biological material compounded bone repair technology

Through the combination of CRISPR-Cas9 gene editing and nano-scale biological materials, the stem cell-biomaterial complex is prepared by electrospinning and 3D printing technology, and the in vivo environment is simulated to induce differentiation, which solves the low binding efficiency of stem cells and biological materials in the prior art. The problem of this problem has achieved efficient bone repair and multifunctionality, significantly improving the bone repair effect and clinical application success rate.

CN118987359APending Publication Date: 2024-11-22SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410945674.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-15
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

In the existing bone repair technology, the binding efficiency of stem cells and biological materials is low, resulting in poor bone tissue regeneration effect, and traditional methods have risks of biocompatibility and immune rejection.

Method used

Stem cells were modified by CRISPR-Cas9 gene editing tool, combined with nano-scale hydroxyapatite and tricalcium phosphate biomaterials, and electrospinning, 3D printing and jet printing technology were used to prepare stem cell-biomaterial complexes, and induce differentiation in vitro Add growth factors and microenvironmental regulators to simulate the in vivo environment, optimize pore size and mechanical properties, and use degradable adhesives and intelligent monitoring devices for precise positioning and care.

Benefits of technology

It significantly improves the osteogenic ability of stem cells and the biological activity of biological materials, shortens the treatment cycle, enhances the bone repair effect, improves biocompatibility and versatility, and ensures that the structure and function of the complex are close to natural bone tissue. It reduces the risk of postoperative displacement, improves the success rate of clinical application and the quality of patient recovery.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118987359A_ABST
    Figure CN118987359A_ABST
Patent Text Reader

Abstract

The invention discloses a stem cell and biological material compounded bone repair technology, which ensures sufficient and high-quality stem cell supply by amplifying bone marrow mesenchymal stem cells and induced pluripotent stem cells from autologous and allogenic sources, optimizes the selection and surface treatment of biological materials, and improves the bone repair efficiency. The stem cell-biological material composite with proper pore size and mechanical property is prepared by using electrostatic spinning, 3D printing and jet printing technologies, a natural bone tissue structure is simulated, in-vitro induced differentiation is performed through an osteogenesis induction culture medium, a composite with osteogenesis potential is formed, the bone repair process is accelerated, and the bone repair effect is improved. In an operation, the complex subjected to induced differentiation is accurately implanted into bone defect and fracture parts, good integration is ensured, and the bone repair effect is comprehensively evaluated and promoted through regular imaging examination and biomechanical test in combination with drug therapy and rehabilitation training.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedical engineering, and more specifically, to a bone repair technology combining stem cells and biomaterials. Background Art

[0002] In recent years, advances in regenerative medicine and biomaterials science have provided new solutions for bone repair, especially the application of stem cell technology. Stem cells have the potential for self-renewal and multidirectional differentiation, and can differentiate into osteoblasts to promote the formation of new bone tissue. However, how to effectively combine stem cells with biomaterials to achieve efficient bone tissue regeneration remains a key issue that needs to be resolved. Mesenchymal stem cells (MSCs) have become a hot topic in bone repair research due to their multidirectional differentiation potential and immunomodulatory function.

[0003] The stem cell and biomaterial composite technology forms a bioactive composite material by implanting stem cells into a biocompatible scaffold. This composite material not only provides a three-dimensional scaffold for cell attachment and growth, but also gradually releases bioactive substances through the degradation of the scaffold material to promote bone tissue regeneration. Through advanced electrospinning and 3D printing technology, stem cells are evenly distributed in the biomaterial scaffold, and growth factors and antibacterial agents are added during stem cell culture and composite material preparation to further enhance osteogenesis and angiogenesis. The stem cell and biomaterial composite technology of the present invention provides a new and efficient solution for the treatment of bone defects and bone injuries, and has significant clinical application value.

[0004] Bone defects and injuries are common medical problems in clinical practice, often caused by trauma, tumor resection, congenital diseases or infections. Traditional bone repair methods mainly include autologous bone transplantation, allogeneic bone transplantation and artificial synthetic material filling. However, each of these methods has its limitations. Although autologous bone transplantation has good biocompatibility, the donor source is limited and the surgery is traumatic; allogeneic bone transplantation faces the risk of immune rejection and infection; artificial synthetic materials are often difficult to achieve ideal repair effects due to poor biocompatibility and difficult-to-control degradation rates.

[0005] Therefore, in order to solve the above technical problems, it is necessary to provide a bone repair technology that combines stem cells and biomaterials. Summary of the invention

[0006] The purpose of the present invention is to provide a bone repair technology of a composite of stem cells and biomaterials to solve the above-mentioned problems.

[0007] In order to achieve the above purpose, the technical solution provided by an embodiment of the present invention is as follows:

[0008] A bone repair technology combining stem cells and biomaterials, comprising the following steps:

[0009] S1. Obtain bone marrow mesenchymal stem cells and induced pluripotent stem cells from autologous and allogeneic sources, expand them in vitro in specific culture media, and obtain sufficient stem cells;

[0010] S2. Select appropriate biomaterials, perform surface treatment and three-dimensional structure design on the biomaterials;

[0011] S3, compounding the expanded stem cells with the pretreated biomaterials to form a stem cell-biomaterial complex, and preparing a composite structure with appropriate pore size and mechanical properties through electrospinning, 3D printing and jet printing technology;

[0012] S4, inducing differentiation of the stem cell-biomaterial complex in vitro using osteogenic induction medium for 2-3 weeks;

[0013] S5. Perform surgery at the bone defect and fracture site and implant the induced differentiated stem cell-biomaterial complex into the defect site;

[0014] S6. Perform regular imaging examinations and biomechanical testing for postoperative care, evaluate the effect of bone repair, and combine drug treatment and rehabilitation training.

[0015] As a further improvement of the present invention, in step S1, the stem cells are modified by the CRISPR-Cas9 gene editing tool to enhance their osteogenic ability and anti-inflammatory immunomodulatory function.

[0016] As a further improvement of the present invention, the biomaterial in step S2 is a composite material containing nano-hydroxyapatite and tricalcium phosphate, and is subjected to plasma treatment and surface functionalization treatment to increase the bioactivity of the material.

[0017] As a further improvement of the present invention, the stem cell-biomaterial complex in step S3 is prepared by electrospinning, 3D printing and jet printing technology, and microenvironmental regulatory factors are introduced during the composite process to simulate the in vivo environment to promote cell behavior.

[0018] As a further improvement of the present invention, during the in vitro differentiation induction process in step S4, growth factors, extracellular matrix components and small molecule compounds are added to the osteogenic induction medium to accelerate osteoblast differentiation.

[0019] As a further improvement of the present invention, the pore size of the stem cell-biomaterial complex ranges from 100 to 500 microns to optimize cell nutrition supply and waste removal.

[0020] As a further improvement of the present invention, when the complex is implanted in step S5, a degradable bioadhesive is used for fixation to enhance initial mechanical stability, and an image navigation system is used for precise positioning and implantation.

[0021] As a further improvement of the present invention, the postoperative care in step S6 includes applying low-intensity pulsed ultrasound and electrical stimulation to promote bone healing and new bone formation, and monitoring the bone repair process in real time through intelligent monitoring equipment.

[0022] As a further improvement of the present invention, antibacterial components, antioxidant components and angiogenesis-promoting components are introduced into the biomaterial in step S2 to enhance the multifunctionality of the composite material, prevent infection, reduce oxidative stress and promote angiogenesis.

[0023] As a further improvement of the present invention, the stem cell-biomaterial complex is tested for biocompatibility and mechanical properties before implantation, and bioprinting is combined with tissue engineering to construct tissue and organ substitutes with complex structures and functions for the repair of large and complex bone defects.

[0024] Compared with the prior art, the advantages of the present invention are:

[0025] (1) This approach uses the CRISPR-Cas9 gene editing tool to modify stem cells to enhance their osteogenic ability and anti-inflammatory immunomodulatory function, thereby improving the functional properties and therapeutic effects of stem cells. A composite material containing nano-hydroxyapatite and tricalcium phosphate is selected, and plasma treatment and surface functionalization treatment are used to improve the material's bioactivity, cell attachment properties and biocompatibility. At the same time, antibacterial ingredients, antioxidant ingredients and pro-angiogenic ingredients are introduced to enhance the material's multifunctionality, effectively prevent infection, reduce oxidative stress and promote angiogenesis.

[0026] (2) This scheme uses electrospinning, 3D printing and jet printing technologies, and introduces microenvironmental regulatory factors to simulate the in vivo environment to promote cell behavior, ensure that the structure and function of the complex are closer to natural bone tissue, improve the cell growth environment, enhance the cell's biological behavior and tissue regeneration ability, and accelerate osteoblast differentiation by adding growth factors, extracellular matrix components and small molecule compounds to the osteogenic induction medium during in vitro differentiation induction, thereby increasing the speed and efficiency of stem cell differentiation into osteoblasts, shortening the treatment cycle and enhancing the bone repair effect.

[0027] (3) The pore size range of the composite in this scheme is set to 100-500 μm to optimize cell nutrition supply and waste removal, ensure the survival and function of cells in the composite material, and improve the quality and efficiency of tissue regeneration. During surgical implantation, a degradable bioadhesive is used to fix the composite to enhance the initial mechanical stability, and an image navigation system is used for precise positioning and implantation, thereby improving the accuracy of the surgery and the initial stability of the composite, reducing the risk of postoperative displacement, and promoting good integration of bone tissue.

[0028] (4) This program uses intelligent monitoring equipment to monitor the progress of bone repair in real time. These auxiliary treatments and monitoring methods can accelerate the bone repair process, provide real-time feedback on the treatment effect, provide personalized rehabilitation plans, and improve the overall treatment effect. The stem cell-biomaterial complex is tested for biocompatibility and mechanical properties before implantation. In combination with bioprinting and tissue engineering technology, tissue and organ substitutes with complex structures and functions are constructed for the repair of large and complex bone defects, which significantly improves the success rate of clinical applications and the quality of patient recovery. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 Schematic diagram of the bone repair technology steps of the present invention. DETAILED DESCRIPTION

[0030] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention; it is obvious that the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments, and all other embodiments obtained by ordinary technicians in this field based on the embodiments of the present invention without making creative work are within the scope of protection of the present invention.

[0031] Embodiment 1:

[0032] See also Figure 1 , a bone repair technology combining stem cells and biomaterials, comprising the following steps:

[0033] S1. Obtain bone marrow mesenchymal stem cells and induced pluripotent stem cells from autologous and allogeneic sources, expand them in vitro in specific culture media, and obtain sufficient stem cells;

[0034] S2. Select appropriate biomaterials, perform surface treatment and three-dimensional structure design on the biomaterials;

[0035] S3, compounding the expanded stem cells with the pretreated biomaterials to form a stem cell-biomaterial complex, and preparing a composite structure with appropriate pore size and mechanical properties through electrospinning, 3D printing and jet printing technology;

[0036] S4, inducing differentiation of the stem cell-biomaterial complex in vitro, using osteogenic induction medium, and the culture time is 2-3 weeks;

[0037] S5. Perform surgery at the bone defect and fracture site and implant the induced differentiated stem cell-biomaterial complex into the defect site;

[0038] S6. Regular imaging examinations and biomechanical testing postoperative care to evaluate bone repair effects, combined with drug treatment and rehabilitation training;

[0039] By expanding bone marrow mesenchymal stem cells and induced pluripotent stem cells from autologous and allogeneic sources, we ensure a sufficient and high-quality supply of stem cells. At the same time, we optimize the selection and surface treatment of biomaterials to improve biocompatibility and mechanical properties. We use electrospinning, 3D printing and jet printing technologies to prepare stem cell-biomaterial complexes with appropriate pore size and mechanical properties to simulate the natural bone tissue structure. We use osteogenic induction medium to induce differentiation in vitro to form a complex with osteogenic potential, thereby accelerating the bone repair process. During surgery, the induced differentiated complex is precisely implanted into the bone defect and fracture site to ensure good integration. Regular imaging examinations and biomechanical tests, combined with drug treatment and rehabilitation training, are used to comprehensively evaluate and promote the bone repair effect.

[0040] In step S1, stem cells are modified using the CRISPR-Cas9 gene editing tool to enhance their osteogenic ability and anti-inflammatory immunomodulatory function. Gene editing not only improves the functional properties of stem cells, making them more effective in the bone repair process, but also enhances their tolerance and regulatory ability in an inflammatory environment, thereby improving the overall therapeutic effect.

[0041] The biomaterial in step S2 is a composite material containing nano-hydroxyapatite and tricalcium phosphate, and is treated by plasma and surface functionalization to increase the bioactivity of the material. These treatment methods improve the cell attachment performance and biocompatibility of the material and promote the generation of new bone tissue.

[0042] In step S2, antimicrobial components, antioxidant components and angiogenesis-promoting components are introduced into the biomaterial to enhance the multifunctionality of the composite material, effectively prevent infection, reduce oxidative stress and promote angiogenesis.

[0043] In step S3, the stem cell-biomaterial complex is prepared by electrospinning, 3D printing and jet printing technology, and microenvironmental regulatory factors are introduced during the composite process to simulate the in vivo environment to promote cell behavior. This method ensures that the structure and function of the complex are closer to natural bone tissue, improves the cell growth environment, and enhances the cell's biological behavior and tissue regeneration ability.

[0044] During the in vitro differentiation induction process in step S4, growth factors, extracellular matrix components and small molecule compounds are added to the osteogenic induction medium to accelerate osteoblast differentiation. By optimizing the components of the medium, the differentiation rate and efficiency of stem cells into osteoblasts are significantly improved, the treatment cycle is shortened, and the bone repair effect is enhanced.

[0045] The pore size range of the stem cell-biomaterial complex is 100-500 microns to optimize cell nutrient supply and waste removal. The pore size setting ensures the survival and function of cells in the composite material, improving the quality and efficiency of tissue regeneration.

[0046] When the complex is implanted in step S5, a degradable bioadhesive is used for fixation to enhance the initial mechanical stability, and an image navigation system is used for precise positioning and implantation. These technical means can improve the accuracy of the surgery and the initial stability of the complex, reduce the risk of postoperative displacement, and promote good integration of bone tissue.

[0047] Postoperative care in step S6 includes the application of low-intensity pulsed ultrasound and electrical stimulation to promote bone healing and new bone formation, and real-time monitoring of the bone repair process through intelligent monitoring equipment. These auxiliary treatments and monitoring methods can accelerate the bone repair process, provide real-time feedback on the treatment effect, provide personalized rehabilitation plans, and improve the overall treatment effect.

[0048] The stem cell-biomaterial complex is tested for biocompatibility and mechanical properties before implantation, and through bioprinting combined with tissue engineering, tissue and organ substitutes with complex structures and functions are constructed for the repair of large and complex bone defects. The safety and effectiveness of the complex are ensured through biocompatibility and mechanical properties testing, which significantly improves the success rate of clinical applications and the quality of patient recovery.

[0049] It can be seen from the above technical solutions that the present invention has the following beneficial effects:

[0050] This program ensures a sufficient and high-quality supply of stem cells by expanding bone marrow mesenchymal stem cells and induced pluripotent stem cells from autologous and allogeneic sources, while optimizing the selection and surface treatment of biomaterials to improve biocompatibility and mechanical properties. Electrospinning, 3D printing and jet printing technologies are used to prepare stem cell-biomaterial complexes with appropriate pore size and mechanical properties to simulate the natural bone tissue structure. Osteogenic induction medium is used to induce differentiation in vitro to form a complex with osteogenic potential, thereby accelerating the bone repair process. During surgery, the induced differentiated complex is precisely implanted into the bone defect and fracture site to ensure good integration. Regular imaging examinations and biomechanical tests, combined with drug treatment and rehabilitation training, are used to comprehensively evaluate and promote the bone repair effect.

[0051] It will be apparent to those skilled in the art that the invention is not limited to the details of the exemplary embodiments described above and that the invention can be implemented in other specific forms without departing from the spirit or essential features of the invention. Therefore, the embodiments should be considered exemplary and non-limiting in all respects, and the scope of the invention is defined by the appended claims rather than the foregoing description, and it is intended that all variations falling within the meaning and scope of the equivalent elements of the claims be included in the invention. Any reference numeral in a claim should not be considered as limiting the claim to which it relates.

[0052] In addition, it should be understood that although the present specification is described according to embodiments, not every embodiment contains only one independent technical solution. This narrative method of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation methods that those skilled in the art can understand.

Claims

1. A bone repair technology using a combination of stem cells and biomaterials, characterized in that: The following steps are involved: S1. Obtain bone marrow mesenchymal stem cells and induced pluripotent stem cells from autologous and allogeneic sources, expand them in vitro in specific culture media, and obtain sufficient stem cells; S2. Select appropriate biomaterials, perform surface treatment and three-dimensional structure design on the biomaterials; S3, compounding the expanded stem cells with the pretreated biomaterials to form a stem cell-biomaterial complex, and preparing a composite structure with appropriate pore size and mechanical properties through electrospinning, 3D printing and jet printing technology; S4, inducing differentiation of the stem cell-biomaterial complex in vitro, using osteogenic induction medium, and the culture time is 2-3 weeks; S5. Perform surgery at the bone defect and fracture site and implant the induced differentiated stem cell-biomaterial complex into the defect site; S6. Perform regular imaging examinations and biomechanical testing for postoperative care, evaluate the effect of bone repair, and combine drug treatment and rehabilitation training.

2. The bone repair technology of stem cell and biomaterial composite according to claim 1, characterized in that: In step S1, stem cells are modified using the CRISPR-Cas9 gene editing tool.

3. The bone repair technology of stem cell and biomaterial composite according to claim 1, characterized in that: The biomaterial in step S2 is a composite material containing nano-hydroxyapatite and tricalcium phosphate, and is subjected to plasma treatment and surface functionalization treatment.

4. The bone repair technology of stem cell and biomaterial composite according to claim 1, characterized in that: In step S3, the stem cell-biomaterial complex is prepared by electrospinning, 3D printing and jet printing technology, and microenvironmental regulatory factors are introduced during the composite process.

5. The bone repair technology of stem cell and biomaterial composite according to claim 1, characterized in that: During the in vitro differentiation induction process in step S4, growth factors, extracellular matrix components and small molecule compounds are added to the osteogenic induction medium.

6. The bone repair technology of stem cell and biomaterial composite according to claim 1, characterized in that: The pore size of the stem cell-biomaterial complex ranges from 100 to 500 microns.

7. The bone repair technology of stem cell and biomaterial composite according to claim 1, characterized in that: When the complex is implanted in step S5, it is fixed with a degradable bioadhesive.

8. The bone repair technology of stem cell and biomaterial composite according to claim 1, characterized in that: The postoperative care in step S6 includes applying low-intensity pulsed ultrasound and electrical stimulation to promote bone healing and new bone formation.

9. The bone repair technology of stem cell and biomaterial composite according to claim 1, characterized in that: In step S2, antibacterial components, antioxidant components and angiogenesis-promoting components are introduced into the biomaterial.

10. The bone repair technology of stem cell and biomaterial composite according to claim 1, characterized in that: The stem cell-biomaterial complex is tested for biocompatibility and mechanical properties before implantation, and tissue and organ substitutes with complex structures and functions are constructed by combining bioprinting with tissue engineering.